Serendo Therapeutics is a biotechnology company advancing precision therapies for autoimmune and chronic inflammatory diseases. Our company is built on differentiated scientific insights into the cellular mechanisms that drive pathological immune activity, with the goal of developing novel treatments for diseases where unmet medical need remains high.

We believe the future of immunology lies in more precise intervention at the biological processes that sustain chronic disease. Our mission is to move treatment beyond symptom management toward deeper, more durable disease control. By combining rigorous science with translational ambition, we aim to help redefine what innovative immunology therapeutics can achieve for patients living with chronic immune-mediated conditions.

Serendo brings together scientific insight, therapeutic focus, and company-building ambition to translate differentiated biology into meaningful clinical potential. As we continue to advance our research and development efforts, we remain focused on building therapies with the potential to make a lasting difference for patients, partners, and the broader field of immunology.

Follow us for updates on our research, partnerships, milestones, and company progress.

Serendo Therapeutics AB

Org chart

Teams

Offices

Serendo Therapeutics AB

Org chart

Teams

Offices

Related companies